A Reversal for Ampliphi Biosciences Corp Is Not Near. The Stock Declines Again

The stock of Ampliphi Biosciences Corp (NYSEMKT:APHB) is a huge mover today! The stock decreased 5.71% or $0.3 during the last trading session, hitting $4.95. About 96,789 shares traded hands or 168.83% up from the average. Ampliphi Biosciences Corp (NYSEMKT:APHB) has risen 6.00% since February 10, 2016 and is uptrending. It has outperformed by 10.97% the S&P500. The move comes after 6 months negative chart setup for the $30.89 million company. It was reported on Mar, 11 by Barchart.com. We have $4.31 PT which if reached, will make NYSEMKT:APHB worth $4.02M less.

Analysts await Ampliphi Biosciences Corp (NYSEMKT:APHB) to reports earnings on April, 20. They expect $-0.46 earnings per share, up 8.00% or $0.04 from last year’s $-0.5 per share. After $-0.30 actual earnings per share reported by Ampliphi Biosciences Corp for the previous quarter, Wall Street now forecasts 53.33% negative EPS growth.

According to Zacks Investment Research, “AmpliPhi Biosciences Corporation, formerly known as Targeted Genetics Corporation, is a biotechnology company which develops anti-bacterial solutions for the treatment of gram negative bacterial infections that are often resistant to existing antibiotic treatments. AmpliPhi Biosciences Corporation is based in Seattle, Washington.”

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Add Comment